Substandard Medicines Worth Rs 1.90 Crore Seized From YCM Hospital; PCMC Blacklists Jejuri Maker and Supplier for Three Years
FDA seized about Rs 1.90 crore of medicines that failed quality tests from YCM Hospital and the maker. PCMC has blacklisted the maker and supplier.

Photo: Pöllö / CC BY 3.0, via Wikimedia Commons
Pimpri-Chinchwad, 21st November 2026: The Maharashtra Food and Drug Administration (FDA) has seized medicines worth about Rs 1.90 crore that failed quality tests, from the central medical store of Pimpri-Chinchwad’s YCM Hospital and from the manufacturer. The Pimpri Chinchwad Municipal Corporation (PCMC) has blacklisted the maker and the supplier for three years.
The drugs were marked “Not of Standard Quality” in lab tests. That label means they failed set quality standards, not that they were fake.
What was seized
According to the Free Press Journal, the FDA took stock worth Rs 1.72 crore from YCM Hospital’s store and Rs 17 lakh from the manufacturer. The packs were labelled “For Government Supply Only”.
The medicines named are Carezinc, Caregil-200, LDLR-5 and a domperidone product.
PCMC Additional Commissioner Kuldeep Jangam disputed the hospital figure, saying the stock held there was worth Rs 11.95 lakh, not Rs 1.72 crore.
How the problem came to light
A patient complained that the medicines were not working. PCMC sent samples to the FDA in February and received the substandard report in July. It then asked the FDA to remove the stock, which has now been done.
Why the value is disputed
The FDA’s figure covers the total stock it seized, while PCMC says the quantity actually held at YCM was much smaller. The difference has not been explained yet. Either way, the medicines have now been removed from the hospital’s store.
Who has been blacklisted
- Manufacturer: Inducare Pharmaceuticals and Research Centre, Jejuri
- Supplier: Shri Vinayak Pharma
Jangam said both were blacklisted for three years in September, purchases of 239 medicines from them were stopped and a fine was imposed.
What the FDA will do next
Girish Hukre, Joint Commissioner (Drugs) for the FDA’s Pune division, said a recall notice has been issued. The FDA has asked where the medicines were bought and distributed, will look into the supply chain and plans to file a case in court. He said no other companies have been reported failing tests so far.
What patients should do
If you were given any of these medicines at YCM or another PCMC facility, do not stop a prescribed treatment on your own. Show the strip to your doctor or the hospital pharmacy and ask for a replacement. Hukre has asked citizens to report quality concerns about medicines to the FDA.
This article is general information, not medical advice. For other city helplines, see our Pune emergency numbers page.
Frequently asked questions
Which medicines were seized from YCM Hospital?
Carezinc, Caregil-200, LDLR-5 and a domperidone product made by Inducare Pharmaceuticals, Jejuri, which failed quality tests.
Are the YCM medicines fake?
The FDA classed them as Not of Standard Quality, meaning they failed quality tests. That does not by itself mean they were fake.
What should I do if I took these medicines?
Do not stop treatment on your own. Consult your doctor or the hospital pharmacy for a replacement.
